Zoledronic Acid Injection

DRUG4 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Peking University Third Hospital, University of Calgary, University of Ioannina

Conditions

Anterior Cruciate Ligament InjuriesAnterior Cruciate Ligament RuptureAnterior Cruciate Ligament TearBone Metastatic Non-small Cell Lung CancerOsteo Arthritis KneePostmenopausal OsteoporosisSpinal Cord InjuriesStroke

Phase 1

Altering Bone Microarchitecture and Mechanics by Off-label Pharmaceutical Intervention Following an Acute Knee Injury

TerminatedNCT05204836

University of CalgaryAnterior Cruciate Ligament Injuries, Anterior Cruciate Ligament Rupture, Anterior Cruciate Ligament Tear +1

Start: 2023-05-16End: 2025-07-03Updated: 2025-12-02

Phase 2

A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Bone Metastatic Non-small Cell Lung Cancer

Start: 2020-09-24End: 2021-11-30Target: 60Updated: 2020-10-12

Phase 4

Clinical Pharmacokinetics and Pharmacodynamics Study of Different Doses of Zoledronic Acid

Peking University Third HospitalPostmenopausal Osteoporosis

Start: 2021-10-31End: 2024-11-30Target: 64Updated: 2021-06-23

Unknown Phase

Continuous Passive Motion Versus Heterotopic Ossification

RecruitingNCT05906056

University of IoanninaSpinal Cord Injuries, Stroke, Traumatic Brain Injury

Start: 2023-05-12End: 2027-03-25Target: 20Updated: 2024-12-06